AstraZeneca PLC (AZNN) — Cash Flow Reinvestment Rate
AstraZeneca PLC (AZNN) has a Cash Flow Reinvestment Rate of 0.55x as of December 2025, reinvesting MX$1.29 Billion (capex MX$1.29 Billion plus investments MX$-2.00 Million) from operating cash flow of MX$2.34 Billion. Explore AZNN capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AstraZeneca PLC Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for AstraZeneca PLC across 12 annual periods. Also explore AstraZeneca PLC balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for AstraZeneca PLC (2014–2025)
Year-by-year capital reinvestment analysis for AstraZeneca PLC. For live market cap and broader valuation context, see AstraZeneca PLC stock valuation.
| Year | Reinvestment Rate | Total Reinvested (MXN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.41x | MX$6.00 Billion | MX$14.57 Billion | MX$5.91 Billion | ▲ +6.2% |
| 2024 | 0.39x | MX$4.60 Billion | MX$11.86 Billion | MX$4.59 Billion | ▼ -39.3% |
| 2023 | 0.64x | MX$6.62 Billion | MX$10.36 Billion | MX$3.39 Billion | ▲ +407.9% |
| 2022 | 0.13x | MX$1.23 Billion | MX$9.81 Billion | MX$1.09 Billion | ▼ -55.8% |
| 2021 | 0.28x | MX$1.70 Billion | MX$5.96 Billion | MX$1.09 Billion | ▼ -53.9% |
| 2020 | 0.62x | MX$2.96 Billion | MX$4.80 Billion | MX$961.00 Million | ▲ +65.9% |
| 2019 | 0.37x | MX$1.10 Billion | MX$2.97 Billion | MX$979.00 Million | ▼ -17.7% |
| 2018 | 0.45x | MX$1.18 Billion | MX$2.62 Billion | MX$1.04 Billion | ▼ -8.8% |
| 2017 | 0.50x | MX$1.77 Billion | MX$3.58 Billion | MX$1.33 Billion | ▼ -67.3% |
| 2016 | 1.52x | MX$6.28 Billion | MX$4.14 Billion | MX$2.31 Billion | ▲ +214.5% |
| 2015 | 0.48x | MX$1.60 Billion | MX$3.32 Billion | MX$1.33 Billion | ▲ +204.0% |
| 2014 | 0.16x | MX$1.12 Billion | MX$7.06 Billion | MX$1.01 Billion | — |